Glass House Brands (GLAS) Current Assets (2020 - 2026)
Glass House Brands (GLAS) posted quarterly Current Assets of $74.4 million for Q1 2026, up 8.47% year-over-year from $68.5 million in Q1 2025, and up 9.75% quarter-over-quarter from $67.7 million in Q4 2025.
Glass House Brands (GLAS) Current Assets (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has reported Current Assets for 7 consecutive years, with $74.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets rose 8.47% year-over-year to $74.4 million; the TTM figure through Mar 2026 stood at $74.4 million (up 8.47% YoY), while the FY2025 annual figure was $67.7 million, up 2.49% from the prior year.
- Current Assets rose to $74.4 million in Q1 2026 per GLAS's latest filing, from $67.7 million in the prior quarter.
- Across five years, Current Assets topped out at $86.5 million in Q2 2025 and bottomed at $37.9 million in Q1 2023.
- Historically, Current Assets has averaged $56.8 million across 5 years, with a median of $52.5 million in 2024.
- Annual changes were most pronounced in 2022 — Current Assets plunged 70.95% — and 2025, when it soared 64.87%.
- Glass House Brands' Current Assets stood at $38.9 million in 2022, then increased by 26.54% to $49.2 million in 2023, then jumped by 34.31% to $66.1 million in 2024, then gained by 2.49% to $67.7 million in 2025, then increased by 9.75% to $74.4 million in 2026.
- Business Quant data shows GLAS's Current Assets at $74.4 million in Q1 2026, $67.7 million in Q4 2025, and $74.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 3.22 Bn |
| 10 | Glass House Brands | 828.45 Mn | 809.90 Mn | 15.77 Mn | 71.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 74.35 Mn |
| Dec 31, 2025 | 67.75 Mn |
| Sep 30, 2025 | 74.34 Mn |
| Jun 30, 2025 | 86.50 Mn |
| Mar 31, 2025 | 68.55 Mn |
| Dec 31, 2024 | 66.10 Mn |
| Sep 30, 2024 | 67.33 Mn |
| Jun 30, 2024 | 52.47 Mn |
| Mar 31, 2024 | 42.08 Mn |
| Dec 31, 2023 | 49.22 Mn |
| Sep 30, 2023 | 59.67 Mn |
| Jun 30, 2023 | 47.30 Mn |
| Mar 31, 2023 | 37.86 Mn |
| Dec 31, 2022 | 38.89 Mn |
| Sep 30, 2022 | 45.26 Mn |
| Jun 30, 2022 | 44.74 Mn |
| Mar 31, 2022 | 42.56 Mn |
| Dec 31, 2021 | 68.62 Mn |
| Sep 30, 2021 | 50.51 Mn |
| Jun 30, 2021 | 154.00 Mn |